Laminar Pharma opens funding round for up to EUR 7m, seeks partners to commercialize its treatment
Laminar Pharma abre ronda de financiación por hasta EUR 7m y busca socios para comercializar su tratamiento
Intel ID : 390753
|
||||
|
||||
|
||||
| Intel ID | 390753 | |
| Value | EUR 7,00m (Approx.) | |
| Native Currency | Euro (EUR) | |
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
30.01.01 Biopharmaceuticals (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|
| Type |
 |
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.